Related Experiment Video
Updated: Feb 14, 2026

In Vitro Thrombosis Test for Ventricular Assist Devices
Published on: March 21, 2025
Signal artefacts in wearable-based biosignal acquisition in patients with ventricular assist devices: the SMART-VADCH
Emanuel Heil1,2,3, Luise Roehrich2,3,4, Lena Reichert2,3,4
1Department of Cardiology, Deutsches Herzzentrum der Charité (DHZC), Angiology and Intensive Care Medicine, Charitéplatz 1, Berlin 10117, Germany.
Aims:
Telemonitoring is increasingly used in cardiovascular care, yet data on the reliability of smartwatch-based biosignal acquisition in patients with advanced heart failure and LVAD support remain limited. This study evaluated the feasibility and accuracy of smartwatch-derived heart rate (HR), oxygen saturation (SpO2), and single-lead ECG measurements in this population.
Methods And Results:
In this prospective, single-centre pilot study, patients without LVAD or with durable (HeartMate 3) or temporary (Impella 5.5) LVADs underwent parallel resting measurements using a consumer smartwatch and standard clinical. Measurements unsuccessful after three attempts were classified as failures. Thirty-eight patients were enrolled (15 heart failure, 15 durable LVAD, 8 temporary LVAD). In patients without LVAD, HR was feasible in all patients and accurate within a 5% tolerance in 93% (95% CI 70-99%). At least one interpretable ECG was obtained in all, although QRS duration met a 10% tolerance in 33%. SpO₂ was feasible and accurate in 93%. In LVAD, HR was feasible in all patients and accurate in 82%. ECG was technically successful in all. QRS complexes were distinguishable in 73% of durable and all temporary LVAD. SpO₂ feasibility was overall limited (36%), but higher in temporary than durable LVAD patients (63% vs. 20%), and accurate when successful. SpO₂ failure was observed in patients without aortic valve opening, with tachycardia >100 bpm, and with darkly pigmented skin.
Conclusion:
The evaluated wrist-worn smartwatch reliably provided HR and ECG measurements in advanced heart failure, including LVAD patients, whereas SpO₂ performance remains limited.
Related Concept Videos
Trial and Error and Algorithm
Clinical Trials: Overview
Clinical Trials
There are four phases in a clinical trial. A phase one...
Light Acquisition
Water and Mineral Acquisition
Endocrine Signaling

